drugset / Trial / NCT01216904
Nicotine Treatment of Impulsivity in Parkinson's Disease
Phase 4
Unknown
20 enrolled
University of Vermont
Parkinson's Disease Foundation · collabThe Parkinson Study Group · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The specific aims of this study are to examine whether treatment with transdermal nicotine improves computer-based laboratory and clinical measures of impulsive and compulsive behaviors in Parkinson's Disease subjects who have recently experienced an impulse control disorder.
Timeline
- Start
- 2010-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nicotine | Unknown | 7 mg | Other |